Search bioRxiv⌕ Search

bioRxiv · 10.1101/2021.08.11.455859

Invalidity of light sensor data in field studies and a proposal of an algorithmic approach for detection and filtering of non-wear time

Abstract

Wearable light sensors are increasingly used in intervention and population-based studies investigating the consequences of environmental light exposure on human physiology. An important step in such analyses is the reliable detection of non-wear time. We observed in light data that days with less wear-time also have lower variability in the light signal, and we sought to test if the standard deviation of the change between subsequent samples can detect this condition. In this study, we propose and validate an easy-to-implement algorithm designed to discriminate between days with a non-wear time >4h ("invalid days") vs. [≤]4h ("valid days") and investigate to which extent values of commonly used physiologically meaningful light variables differ between invalid days, valid days, and algorithm-selected non-wear days. We used 83 days of light data from a field study with high participant compliance, complemented by 47 days of light data where free-living individuals were instructed not to wear the sensor for varying amounts of time. Light data were recorded every two minutes using the pendant-worn f.luxometer light sensor; validity was derived from daily logs where participants recorded all non-wear time. The algorithm-derived score discriminated well between valid and invalid days (area under the curve (AUC): 0.77, 95% CI: 0.67-0.87). The best cut-off value (i.e., highest Youden index) correctly recognized valid days with a probability of 87% ("sensitivity"), and invalid days with a probability of 63% ("specificity"). Values of various light variables derived from algorithm-selected days only (median: 264.3 (Q1: 153.6, Q3: 420.0) for 24h light intensity (in lux); 496.0 (404.0, 582.0) for time spent above 50-lux) gave values close to those derived from self-reported valid days only. However, these values did not significantly differ when derived across all days compared to self-reported valid days. Our results suggest that our proposed algorithm discriminates well between valid and invalid days. However, in high compliance cohorts, distortions in aggregated light measures of individual-level environmental light recordings across days appear to be small, making the application of our algorithm optional, but not necessary.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hunt, L. C., Fritz, J., Herf, M., Vetter, C.. 2021-08-12. Invalidity of light sensor data in field studies and a proposal of an algorithmic approach for detection and filtering of non-wear time. https://doi.org/10.1101/2021.08.11.455859

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗